Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $320.35 | $19.36 | 1,554.97% | 6,407.00x | 96.02x | 7.10x | 8.59x | 6.19x | $529.27M | 1.50% | $4.13B | 37.48 | $33.35B | 104.87 | ||
| NVO | NOVO NORDISK A S | $56.26 | $149.56 | -62.38% | 15.65x | 2.44x | 5.14x | 9.55x | 0.16x | $9.34B | 3.74% | $26.18B | 5.89 | $260.64B | 10.51 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $406.40 | $36.94 | 1,000.28% | 1,310.97x | 58.40x | 16.64x | 229.55x | 4.26x | $221.36M | 0.41% | $233.89M | 1.78 | $55.41B | 364.75 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.68 | $17.43 | 144.93% | 87.10x | 24.81x | 5.33x | 6.04x | 1.08x | $101.73M | 3.19% | $535.38M | 7.17 | $3.07B | 57.30 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.31 | $16.51 | -49.66% | 17.31x | 14.61x | 5.51x | 3.51x | 0.22x | -$23.64M | -5.09% | $133.17M | 2.38 | $476.11M | 7.08 | ||
| CORT | CORCEPT THERAPEUTICS INC | $35.78 | $43.32 | -17.41% | 35.78x | 32.56x | 5.00x | 5.96x | 0.35x | $162.57M | 4.39% | $631.90M | 6.10 | $3.64B | 55.24 | ||
| VCEL | VERICEL CORP | $39.34 | $9.59 | 310.25% | 151.31x | 67.66x | 7.68x | 6.18x | 1.79x | $20.38M | 1.03% | $321.86M | 6.38 | $1.99B | 67.80 | ||
| ARGX | ARGENX SE | $803.74 | $363.93 | 120.85% | 32.12x | 27.23x | 25,927.10x | 6.84x | 1.35x | $467.72M | 0.95% | $7.17B | 117.50 | $46.65B | 57.50 | ||
| KRYS | KRYSTAL BIOTECH INC | $249.39 | $116.36 | 114.33% | 36.14x | 31.08x | 19.35x | 6.36x | 1.20x | $166.02M | 2.30% | $1.14B | 39.30 | $6.85B | 35.43 | ||
| TECH | BIO-TECHNE CORP | $65.28 | $16.37 | 298.79% | 130.56x | 32.29x | 8.34x | 5.17x | 1.78x | $224.06M | 2.21% | $1.97B | 12.65 | $10.42B | 47.18 | ||
| GMAB | GENMAB A | $33.10 | $128.71 | -74.28% | 14.13x | 1.89x | 5.96x | 3.70x | 0.11x | $1.19B | 5.62% | $5.75B | 8.96 | $19.63B | 9.81 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.16 | $19.20 | -73.13% | 3.25x | -95.73x | 737.14x | 1.63x | 0.19x | -$82.36M | -29.42% | $171.23M | 3.16 | $220.51M | 2.45 | ||
| ADMA | ADMA BIOLOGICS INC | $18.34 | $12.79 | 43.38% | 20.84x | 20.43x | 8.96x | 10.12x | 0.88x | $40.73M | 0.93% | $431.19M | 1.81 | $4.38B | 25.43 | ||
| XOMA | XOMA ROYALTY CORP | $26.45 | $15.92 | 66.09% | 32.65x | 84.13x | 6.82x | 3.72x | 0.87x | -$12.41M | -3.86% | $87.94M | 7.25 | $368.97M | 13.79 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.44 | $9.90 | 56.03% | 26.62x | 16.19x | 7.65x | 5.57x | 0.87x | $119.87M | 5.89% | $365.77M | 2.78 | $2.04B | 19.71 | ||
| VCYT | VERACYTE INC | $45.64 | $12.39 | 268.30% | 117.03x | 43.38x | 7.26x | 2.87x | 1.66x | $98.21M | 2.73% | $1.26B | 15.98 | $3.33B | 58.44 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $196.02 | $72.70 | 169.62% | 84.86x | 23.29x | 15.28x | 4.06x | 1.22x | $30.76M | 0.80% | $950.17M | 48.53 | $4.17B | 40.48 | ||
| CRMD | CORMEDIX INC | $11.26 | $17.92 | -37.16% | 4.96x | 4.47x | 3.99x | 2.37x | 0.86x | $74.42M | 8.70% | $374.13M | 4.93 | $987.59M | 8.80 | ||
| MNKD | MANNKIND CORP | $5.62 | $2.79 | 101.09% | 56.20x | 51.23x | 5.49x | -38.74x | 0.93x | $43.39M | 2.51% | -$44.55M | -0.15 | $1.96B | 26.76 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.76 | $4.34 | 55.60% | 25.04x | 22.47x | 4.33x | 7.63x | 0.89x | $21.15M | 3.92% | $70.68M | 0.89 | $478.25M | 21.08 | ||
| RPRX | ROYALTY PHARMA PLC | $40.65 | $47.47 | -14.37% | 23.10x | 7.85x | 7.47x | 2.44x | 0.40x | $2.11B | 12.03% | $9.62B | 22.28 | $31.47B | 30.14 | ||
| EXEL | EXELIXIS INC | $43.68 | $36.76 | 18.81% | 17.76x | 13.82x | 5.12x | 5.42x | 0.71x | $779.77M | 6.65% | $2.16B | 8.05 | $11.51B | 12.41 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $468.38 | $191.44 | 144.66% | 32.73x | 22.91x | 10.21x | 6.86x | 1.59x | $3.34B | 2.79% | $17.32B | 67.76 | $115.73B | 24.82 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.77 | $3.59 | -50.72% | 25.29x | 10.01x | 2.27x | 2.69x | 0.20x | -$11.69M | -8.31% | $52.91M | 0.67 | $136.88M | 15.43 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.07 | $51.68 | 16.23% | 22.08x | 13.33x | 3.73x | 1.91x | 0.62x | $832.13M | 7.21% | $6.06B | 31.54 | $10.89B | 14.09 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $23.94 | $6.71 | 256.63% | 68.40x | -21.56x | 2.98x | 7.55x | 1.88x | $78.64M | 2.60% | $401.17M | 3.17 | $3.02B | 32.38 | ||
| HALO | HALOZYME THERAPEUTICS INC | $73.13 | $81.21 | -9.95% | 14.96x | 8.82x | 6.90x | 17.07x | 0.51x | $602.40M | 7.03% | $503.92M | 4.30 | $9.69B | 11.46 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.75 | $61.56 | -40.30% | 11.38x | 8.70x | 2.56x | 2.53x | 0.32x | $296.89M | 14.04% | $835.12M | 14.51 | $1.64B | 6.08 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.58 | $22.76 | -0.80% | 12.61x | 11.58x | 4.79x | 3.02x | 0.67x | $234.54M | 8.47% | $920.25M | 7.51 | $2.09B | 6.45 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $776.54 | $414.82 | 87.20% | 17.87x | 16.86x | 5.65x | 2.64x | 1.75x | $4.22B | 5.25% | $30.96B | 298.82 | $81.81B | 14.32 | ||
| MDXG | MIMEDX GROUP INC | $6.40 | $5.09 | 25.83% | 22.86x | 25.61x | 2.41x | 3.97x | 0.68x | $66.82M | 7.05% | $238.95M | 1.61 | $823.98M | 11.91 | ||
| INVA | INNOVIVA INC | $19.31 | $19.49 | -0.94% | 10.22x | 8.84x | 3.43x | 1.43x | 0.83x | $196.54M | 14.74% | $1.01B | 14.63 | $1.22B | 5.70 | ||
| UTHR | UNITED THERAPEUTICS CORP | $502.71 | $252.75 | 98.90% | 17.65x | 16.90x | 7.04x | 3.28x | 2.10x | $1.12B | 5.10% | $6.59B | 150.46 | $20.30B | 11.45 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.94 | $12.42 | 116.84% | 17.16x | 33.46x | 4.34x | 4.97x | 2.96x | $197.81M | 4.35% | $917.27M | 5.43 | $4.33B | 15.06 | ||
| INCY | INCYTE CORP | $106.66 | $77.77 | 37.14% | 17.66x | 13.25x | 4.34x | 4.50x | 0.92x | $1.20B | 5.74% | $4.65B | 23.77 | $18.52B | 11.01 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.